![Christiana Stamoulis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 30/06/2026
En la actualidad, Christiana Stamoulis es Directora Financiera y Vicepresidenta Ejecutiva de Incyte Corp. La Sra. Stamoulis también forma parte del consejo de administración de Hologic, Inc. En su trayectoria profesional anterior fue Presidenta y Directora Financiera de Cogent Biosciences, Inc., Vicepresidenta Senior de Estrategia y Desarrollo Comercial de Vertex Pharmaceuticals, Inc. y Directora General de la División de Banca de Inversión de Citigroup, Inc. y Vicepresidenta de Goldman Sachs & Co. LLC. La Sra. Stamoulis se licenció en el Massachusetts Institute of Technology y obtuvo un MBA en la MIT Sloan School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INCYTE CORPORATION 0,03 % | 14/04/2026 | 57.534 ( 0,03 % ) | 7 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MALLINCKRODT PLC | Director Financiero/CFO | 01/09/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| HOLOGIC, INC. | Director/Miembro de la Junta | 07/04/2026 |
| INCYTE CORPORATION | Director Financiero/CFO | 16/09/2025 |
| COGENT BIOSCIENCES, INC. | Director Financiero/CFO | 31/01/2019 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/12/2013 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/01/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
